Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pancreatic proteases are a collective group of protein-digesting enzymes secreted by the exocrine pancreas into the small intestine. Their main members—trypsin, chymotrypsin, carboxypeptidase, and elastase—are synthesized as inactive precursors (zymogens) and activated in the duodenum, where they catalyze the hydrolysis of dietary proteins into oligopeptides and free amino acids. Pancreatic proteases are essential for normal digestion and nutrient absorption. Deficiency leads to malnutrition and clinical syndromes such as exocrine pancreatic insufficiency. Therapeutically, replacement enzyme preparations are used to treat malabsorption due to pancreatic disease. The term "pancreatic protease" is generic; scientifically, individual enzymes should be specified for clarity and structured data use.
Digestive supplementation: Enzyme mixtures break down dietary proteins to oligopeptides and amino acids; supplements restore digestive function in pancreatic insufficiency. Inhibition (experimental): Protease inhibitors block enzyme activity, used mainly for laboratory or experimental indications.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pancreatic protease.